ERBB2 and neoplasm: Factors found to be associated with poorer outcomes are high tumor grade, hormone receptors (HR) negative status, young age at diagnosis, high Ki-67 values, lympho-vascular invasion, and human epidermal growth factor receptor 2 (HER2) expression [4,5,6].